Viewing Study NCT02011893


Ignite Creation Date: 2025-12-25 @ 1:09 AM
Ignite Modification Date: 2025-12-25 @ 11:20 PM
Study NCT ID: NCT02011893
Status: COMPLETED
Last Update Posted: 2019-01-30
First Post: 2013-12-10
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: SUNBURST (Success Using Neuromodulation With BURST) Study
Sponsor: Abbott Medical Devices
Organization:

Study Overview

Official Title: Success Using Neuromodulation With BURST (SUNBURST™) Study
Status: COMPLETED
Status Verified Date: 2019-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SUNBURST
Brief Summary: The purpose of the study is to demonstrate the safety and efficacy of the Prodigy system for the treatment of chronic intractable pain of the trunk and/or limbs.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: